SCHEMBL27433237

SCHEMBL27433237

COc1cc2c(cc1F)N(C)C(=O)CO2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.45
HTR2C P28335 1/20 0.45
ALOX5 P09917 1/20 0.41
CYP11B2 P19099 2/20 0.40
CYP11B1 P15538 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRA5 P31644 1/20 0.40
PDE3B Q13370 2/20 0.39
PDE3A Q14432 2/20 0.39
KDM4E B2RXH2 1/20 0.38
GAA P10253 1/20 0.38
HTR7 P34969 1/20 0.37
GPR55 Q9Y2T6 1/20 0.36
DRD2 P14416 1/20 0.36
HTR2A P28223 1/20 0.36
MCHR1 Q99705 1/20 0.36
CHRM1 P11229 1/20 0.35
SCN9A Q15858 3/20 0.35
MAP3K5 Q99683 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30954100 1.00 HTR1A (0.45) HTR1AHTR2CALOX5CYP11B2CYP11B1
SCHEMBL30954116 0.85 HTR1A (0.46) HTR1AHTR2CALOX5CYP11B2CYP11B1
SCHEMBL13849355 0.85 HTR1A (0.46) HTR1AHTR2CALOX5CYP11B2CYP11B1
SCHEMBL4103368 0.82 HTR1A (0.45) HTR1AHTR2CALOX5CYP11B2CYP11B1
SCHEMBL27432475 0.82 HTR1A (0.45) HTR1AHTR2CCYP11B2CYP11B1PDE3B
SCHEMBL6619979 0.80 LMNA (0.54) HTR1AHTR2CCYP11B2CYP11B1PDE3B
SCHEMBL30659587 0.79 HTR1A (0.45) HTR1AHTR2CCYP11B2CYP11B1PDE3B
SCHEMBL26654576 0.79 HTR1A (0.45) HTR1AHTR2CCYP11B2CYP11B1PDE3B
SCHEMBL29209156 0.79 PDE3B (0.43) HTR1AHTR2CALOX5CYP11B2CYP11B1
SCHEMBL27432572 0.79 CYP11B2 (0.42) HTR1AHTR2CALOX5CYP11B2CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed